Dingdang Health Technology Group Ltd. (HKG:9886)
Hong Kong
· Delayed Price · Currency is HKD 0.3450
-0.0050 (-1.43%)
May 2, 2025, 2:48 PM HKT
HKG:9886 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2018 - 2019 |
| Revenue | 4,669 | 4,857 | 4,329 | 3,679 | 2,229 | Upgrade
|
| Revenue Growth (YoY) | -3.86% | 12.19% | 17.68% | 65.07% | 74.71% | Upgrade
|
| Cost of Revenue | 3,131 | 3,346 | 2,879 | 2,516 | 1,462 | Upgrade
|
| Gross Profit | 1,538 | 1,511 | 1,450 | 1,162 | 766.19 | Upgrade
|
| Selling, General & Admin | 1,691 | 1,723 | 1,687 | 1,728 | 836.74 | Upgrade
|
| Research & Development | 61.19 | 64.98 | 88.95 | 96.16 | 82.07 | Upgrade
|
| Other Operating Expenses | - | - | - | - | 8.72 | Upgrade
|
| Operating Expenses | 1,754 | 1,789 | 1,776 | 1,823 | 929.17 | Upgrade
|
| Operating Income | -215.18 | -278.25 | -326.42 | -660.65 | -162.98 | Upgrade
|
| Interest Expense | -8.89 | -7.88 | -7.92 | -17.78 | -6.06 | Upgrade
|
| Interest & Investment Income | 28.73 | 36.39 | 17.15 | 4.17 | 3.54 | Upgrade
|
| Earnings From Equity Investments | -1.56 | -2.45 | - | - | -0.26 | Upgrade
|
| Currency Exchange Gain (Loss) | 7.74 | 5.15 | 14.37 | 11.92 | - | Upgrade
|
| Other Non Operating Income (Expenses) | 17.94 | 16.36 | -2,541 | -929.42 | -745.13 | Upgrade
|
| EBT Excluding Unusual Items | -171.22 | -230.68 | -2,843 | -1,592 | -910.88 | Upgrade
|
| Impairment of Goodwill | -198.92 | - | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Investments | 10 | 9.95 | 11.26 | 10.27 | 8.95 | Upgrade
|
| Gain (Loss) on Sale of Assets | -0.74 | -0.07 | -0.01 | -0.34 | 1.05 | Upgrade
|
| Asset Writedown | -6.85 | - | - | - | - | Upgrade
|
| Other Unusual Items | -2.4 | -0.42 | 0.06 | -0.03 | - | Upgrade
|
| Pretax Income | -370.12 | -221.23 | -2,832 | -1,582 | -900.89 | Upgrade
|
| Income Tax Expense | 9.87 | 9.64 | 10.13 | 17.12 | 18.79 | Upgrade
|
| Earnings From Continuing Operations | -379.99 | -230.87 | -2,842 | -1,599 | -919.68 | Upgrade
|
| Minority Interest in Earnings | 3.49 | 5.06 | 8.88 | 20.95 | -4.57 | Upgrade
|
| Net Income | -376.5 | -225.81 | -2,833 | -1,578 | -924.25 | Upgrade
|
| Net Income to Common | -376.5 | -225.81 | -2,833 | -1,578 | -924.25 | Upgrade
|
| Shares Outstanding (Basic) | 1,323 | 1,339 | 841 | 477 | 255 | Upgrade
|
| Shares Outstanding (Diluted) | 1,323 | 1,339 | 841 | 477 | 255 | Upgrade
|
| Shares Change (YoY) | -1.21% | 59.17% | 76.33% | 87.06% | - | Upgrade
|
| EPS (Basic) | -0.28 | -0.17 | -3.37 | -3.31 | -3.62 | Upgrade
|
| EPS (Diluted) | -0.28 | -0.17 | -3.37 | -3.31 | -3.62 | Upgrade
|
| Free Cash Flow | -36.45 | -19.1 | -255.57 | -315.96 | -212.64 | Upgrade
|
| Free Cash Flow Per Share | -0.03 | -0.01 | -0.30 | -0.66 | -0.83 | Upgrade
|
| Gross Margin | 32.95% | 31.10% | 33.49% | 31.60% | 34.38% | Upgrade
|
| Operating Margin | -4.61% | -5.73% | -7.54% | -17.96% | -7.31% | Upgrade
|
| Profit Margin | -8.06% | -4.65% | -65.45% | -42.90% | -41.47% | Upgrade
|
| Free Cash Flow Margin | -0.78% | -0.39% | -5.90% | -8.59% | -9.54% | Upgrade
|
| EBITDA | -161.59 | -234.36 | -280.87 | -613.63 | -137.81 | Upgrade
|
| EBITDA Margin | -3.46% | -4.83% | -6.49% | -16.68% | -6.18% | Upgrade
|
| D&A For EBITDA | 53.58 | 43.89 | 45.55 | 47.02 | 25.17 | Upgrade
|
| EBIT | -215.18 | -278.25 | -326.42 | -660.65 | -162.98 | Upgrade
|
| EBIT Margin | -4.61% | -5.73% | -7.54% | -17.96% | -7.31% | Upgrade
|
| Advertising Expenses | - | - | - | - | 121.91 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.